logo
Plus   Neg
Share
Email

Pfizer Reaches Global Agreement With AbbVie; To Withdraw Pending Litigation

Pfizer Inc. (PFE) said Friday that it has signed licensing agreements with AbbVie Inc. (ABBV), resolving all global intellectual property matters for Pfizer's proposed adalimumab biosimilar.

Pfizer noted that all litigation pending between the parties will be withdrawn. The financial details of the agreements are confidential.

Under the terms of the agreements, AbbVie has granted Pfizer a non-exclusive patent license for the use and sale of Pfizer's proposed adalimumab biosimilar for many countries around the world.

Pfizer may launch its adalimumab biosimilar upon approval by the European Medicines Agency in Europe. In the U.S., the license period will begin on November 20, 2023.

"This settlement will facilitate patient access to Pfizer's proposed adalimumab biosimilar which we expect to be an important addition to our broad portfolio of biosimilar medicines," said Richard Blackburn, Global President, Inflammation and Immunology at Pfizer.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amazon Inc. is leading a new $575 million investment in British food delivery company Deliveroo, intensifying the e-commerce giant's competition with rival Uber and its Uber Eats service. Deliveroo noted that Amazon is set to be the largest investor in the Series G preferred shared funding round. With the latest funding round, Deliveroo has raised $1.53 billion. While reporting financial results for the first quarter on Friday, Deere & Co. (DE) slashed its earnings and revenue growth guidance for the full-year 2019. The company said the lower forecast is partly a result of actions taken by it to prudently manage field inventories, which will cause production... European Union regulators on Thursday fined five global banks a total of 1.07 billion euros, or $1.2 billion, for participating in foreign exchange spot trading cartels and manipulating the foreign-exchange currency market. The five banks are Barclays, Royal Bank of Scotland, Citigroup, JPMorgan Chase and Japan's MUFG Bank, formerly known as Bank of Tokyo-Mitsubishi.
Follow RTT